Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Effect of Anselamimab on Cardiac Structure and Function in Patients With Light Chain Amyloidosis: Insights From the CARES Clinical Trials.
Journal: Circulation
Published: August 30, 2026
Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Secondary Analysis of the HELIOS-B Randomized Clinical Trial.
Journal: JAMA cardiology
Published: August 26, 2026
Left Atrial Structure and Function, Clinical Outcomes, and Efficacy of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: A Secondary Analysis of the HELIOS-B Randomized Clinical Trial.
Journal: JAMA cardiology
Published: August 19, 2026
Comorbidity Burden in Transthyretin Amyloidosis With Cardiomyopathy: Insights From the HELIOS-B Trial.
Journal: JACC. Heart failure
Published: March 27, 2026
Consistent Efficacy of Vutrisiran Across Sexes in Transthyretin Cardiac Amyloidosis: Evidence from the HELIOS-B Trial.
Journal: European journal of heart failure
Published: January 14, 2026
Atrial Mechanical Contraction Predicts Cerebrovascular Risk in Patients With Transthyretin Amyloid Cardiomyopathy and Sinus Rhythm.
Journal: Journal of the American College of Cardiology
Published: October 18, 2025
Differences in Characteristics and Clinical Outcomes According to Age in Patients Following High-Risk Myocardial Infarction: Insights from PARADISE-MI.
Journal: The American journal of cardiology
Published: May 19, 2025
Detection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial Intelligence.
Journal: Circulation. Heart failure
Published: May 14, 2025
Capturing Totality of Treatment Effects: A Model-Free Approach to Analyzing Multiple Event-Time Data From Heart Failure Studies.
Journal: JACC. Heart failure
Published: April 09, 2025
Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With Cardiomyopathy.
Journal: Journal of the American College of Cardiology
Published: April 04, 2025
Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial.
Journal: Nature medicine
Published: February 03, 2025
Alcoholic Cardiomyopathy-Attributed Mortality in the United States, 2010 to 2020.
Journal: JACC. Heart failure
Published: January 27, 2025
Last Updated: 09/26/2026